Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease

Matthias Girndt, Patricia Houser, Roberto Manllo-Karim, John E. Ervin, Chaim Charytan, S. P. Chow, Margarita Symonian-Silver, Lawrence Lehrner, Douglas Linfert, Douglas Shemin,

Vaccine · 2023 · 19 citations · 17 references

DOIFull text

Open access

Abstract

gov: NCT01282762.

References

17